Cancer Center at Illinois team finds treatment of liver metastases in breast cancer patients improved by low-carb diets

Urbana, Ill. – A new study by Cancer Center at Illinois Education Program Leader, Zeynep Madak-Erdogan and her team, have found a new mechanism of endocrine resistance in breast cancers metastasized to the liver. Madak-Erdogan is an associate professor in the Department of Food Science and Human Nutrition.

The study, published in Molecular Cancer Research, a journal of the American Association for Cancer Research, found that liver metastases rely on increased amounts of glucose, revealing the possibility of a dietary intervention to reduce tumor burden and increase treatment efficacy.

Read more from Cancer Center at Illinois.